Meribank Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Meribank Biotech has a total shareholder equity of NT$671.2M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.1B and NT$390.8M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
Interest coverage ratio | n/a |
Cash | NT$399.46m |
Equity | NT$671.20m |
Total liabilities | NT$390.81m |
Total assets | NT$1.06b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4724's short term assets (NT$570.2M) exceed its short term liabilities (NT$126.9M).
Long Term Liabilities: 4724's short term assets (NT$570.2M) exceed its long term liabilities (NT$263.9M).
Debt to Equity History and Analysis
Debt Level: 4724 is debt free.
Reducing Debt: 4724 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4724 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 4724 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 6.4% each year